[孕激素治疗中的阴道瘤:应该采取什么态度?]
Emma Cornu1, Axelle Pintiaux1, Gilles Reuter2
1Service de Gynécologie, CHU Liège, Belgique.
Revue medicale de Liege
|October 13, 2023
概括
使用高剂量的孕激素,包括诺美格斯特酸盐和马丁酸盐,会增加脑膜瘤的风险. 医生应该使用最小的有效剂量,限制持续时间,并监测患者的这种脑瘤.
科学领域:
- 内分泌学 在内分泌学.
- 神经瘤学神经瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自2007年以来,高剂量赛普罗特酸与脑膜瘤风险之间的关联已被确立.
- 最近的证据表明,诺美格斯特酸盐和马丁酸盐与脑膜瘤的发展有关.
研究的目的:
- 审查与特定孕激素药物相关的脑膜瘤风险.
- 提供关于在临床实践中安全使用孕激素的指导.
主要方法:
- 对前列腺激素使用和脑膜瘤风险研究的文献综述.
- 分析累积剂量和治疗持续时间对脑膜瘤发病率的影响.
主要成果:
- 脑膜瘤的风险增加与诺梅格斯特酸 (在5年后12倍) 和丁酸 (在3.5年后7倍).
- 风险取决于剂量,并且随着治疗持续时间而增加.
结论:
- 由于脑膜瘤风险,建议在开处高剂量的孕激素时谨慎使用.
- 建议包括使用最小有效剂量,限制治疗持续时间和临床/成像监测.
- 如果发生脑膜瘤,建议停止孕激素治疗.
相关概念视频
Mitral Valve Prolapse III: Nursing Management
14
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
14
Open Angle Glaucoma: Treatment
471
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
471
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
192
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
192
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Stenosis IV: Nursing Management
13
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
13


